Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Treating sickle cell disease by targeting HbS polymerization
authors: Eaton WA, Bunn HFsummary/abstract:
Although the root cause of sickle cell disease is the polymerization of hemoglobin S (HbS) to form fibers that make red cells less flexible, most drugs currently being assessed in clinical trials are targeting the downstream sequelae of this primary event. Less attention has been devoted to investigation of the multiple ways in which fiber formation can be inhibited. In this article, we describe the molecular rationale for 5 distinct approaches to inhibiting polymerization and also discuss progress with the few antipolymerization drugs currently in clinical trials.organization: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda; Brigham and Women's Hospital, Boston; Harvard Medical School, Boston
read more full text
Sickle Cell DiseaseSickle cell disease (SCD) is a group of ...
Beyond Hydroxyurea: New and Old Drugs in the Pipeline for Sickle Cell DiseaseDespite Food and Drug Administration (FD...
Computer models provide new understanding of sickle cell diseaseComputer models developed by Brown Unive...
Small chips, big impact: MSU researcher studies cardiovascular, sickle cell diseaseA Mississippi State University researche...
Chip-based Models Mimic Organs to Advance Understanding of Sickle Cell DiseaseResearchers at Mississippi State Univers...
Marina Jerebtsova, PhDDr Marina Jerebtsova is an assistant pro...
Researchers ID key drivers of heart complications in sickle cell anemiaStudy opens path to earlier diagnosis, t...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.